Probiotics Composition Harbors Against Osteoarthritis and Inflammation through GABA in Mice
Abstract Background: Osteoarthritis (OA) is an age-related disease with multifactorial etiology and its prevalence growing globally. The role of Gut microbiota is inevitable concerning musculoskeletal disease and health. A method of controlling inflammation and cartilage destruction through changes in gut microbiota is proposed. Previously reported data lack the specific approach to microbial clusters and biomarkers in understanding the interactions between host and microbiome.Method: We adopted a novel approach to elaborate the positive influence of S. thermophilus and L. pentosus to treat Anterior cruciate ligament transection (ACLT) induced OA in vivo. For in vitro analysis Human Chondrocyte Cell Line (C28/I2) was used to analyze chondrogenic effect of microbes and GABA. Tukey’s multiple-comparisons test or Two-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli test were used to statistically analyze the data.Results: The gut microbiota-joint axis promoted chondrogenesis and inhibited catabolism. Selected bacteria produced GABA as postbiotic. This study is the first to represent the chondrogenic and protective effects of γ-aminobutyric acid (GABA) on human chondrocytes and cartilage tissue in mice. Oral administration of it down-regulated cartilage degradation in OA-induced mice and decreased inflammation.Conclusion: We speculated the positive results from GABA and probiotics producing GABA against OA. GABA may have functional roles in chondrocyte maturation /differentiation. This data provides a foundation for further studies to elucidate the role of GABA producing microbes and GABA in the regulation of cartilaginous cell proliferation. These findings open future horizons to understand the gut-joint axis and for the treatment of OA. Thus probiotic / GABA therapy could act as a nutraceutical modulator for OA.